Approximately 33,000 Europeans die each year from antibiotic-borne antibiotic results, according to the European Center for Disease Prevention and Control (ECDC), whose report states that the effects of these diseases are comparable to the effects of fatal cases of influenza, tuberculosis and HIV together.
The ECDC analysis has revealed that since 2007, a number of bacterial resistant bacterial infections have been increased and numerous bacterial cases are resistant even to the most potent antibiotics in the carbapenem – CRE group.
These are dangerous and difficult to treat enterobacterial diseases resistant to this type of antibiotic among hospitalized patients, says Al Jazeera Balkans.
The last line of defense
Carbapenem is a broad spectrum of beta-lactam antibiotics and often the last line of defense in multiple resistant bacteria, Hina reports.
Exactly because of this, CRE is resistant to virtually all antibiotics in clinical practice, and therefore the high mortality of patients with these bacteria in the blood is not surprising.
"The data are worrying because these antibiotics are the last line of defense in multiple resistant bacteria," ECDC said in a statement.
"When these antibiotics cease to be effective, it is very difficult and in many cases it is impossible to cure the infection."
Experts estimate that about 70% of bacteria that cause infections are already resistant to at least one antibiotic commonly used in their treatment.
ECDC study, the results of which are published in the professional journal Lancet Infectious Diseases, focused on five types of infections caused by bacteria resistant to known antibiotics in the European Union and the EEA.
It has been found that in 75% of cases it is a matter of so-called hospital infections.
Dissemination of resistant bacterial species
Overbacteria are rapidly spreading due to the excessive use of antibiotics in intensive care units, where patients are the healthiest and the most potent drugs are systematically prescribed.
"Strategies for the prevention and control of antibiotic-resistant bacteria require concerted action by the EU and the EEA at global level," the report said, adding that given the variation in the number of antibiotic-resistant cases and bacteria in EU-H prevention and control must be adapted to the situation of a particular country.
Easy availability, prescription without sufficient indication and excessive use of antibiotics in agriculture have caused the emergence and spread of resistant bacterial species.
Today, many bacteria in their genome contain a large number of resistance genes and are resistant to various classes of antibiotics.
At the same time, some causes in the not so distant future could become resistant to all available antimicrobial drugs, so many experts warn that we are approaching the so-called post-antibiotic era.